ATXN3 Gene Spinocerebellar Ataxia Type 3 Autosomal Dominant NGS Genetic DNA Test
Introduction to the Test
The ATXN3 Gene Spinocerebellar Ataxia Type 3 Autosomal Dominant NGS Genetic DNA Test is designed to identify mutations in the ATXN3 gene, which are responsible for Spinocerebellar Ataxia Type 3 (SCA3), a progressive neurodegenerative disorder. Understanding your genetic predisposition is crucial for early diagnosis and management of this condition.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to detect mutations in the ATXN3 gene. These mutations can lead to the development of neurological disorders characterized by motor dysfunction, coordination issues, and other debilitating symptoms.
Who Should Consider This Test?
Individuals who exhibit symptoms such as:
- Unexplained coordination problems
- Difficulty with balance and walking
- Family history of Spinocerebellar Ataxia
are encouraged to consider this test. Additionally, those with risk factors, including a family history of neurological disorders, should also seek this genetic evaluation.
Benefits of Taking the Test
- Early detection of genetic mutations associated with SCA3.
- Informed decisions regarding treatment and lifestyle adjustments.
- Access to genetic counseling for affected families.
Understanding Your Results
Results will indicate whether a mutation in the ATXN3 gene is present. A positive result can guide patients and their families in understanding their risk and planning for future health management. Genetic counseling is recommended to help interpret these results and discuss potential implications.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 400000 NGN | 560000 NGN |
Book Your Test Today!
Don’t wait to understand your genetic health. Book the ATXN3 Gene Spinocerebellar Ataxia Type 3 Autosomal Dominant NGS Genetic DNA Test today! For more information or to schedule your appointment, call or WhatsApp us at +2348110567037.
